The inclusion of both established biomarkers (e.g., PlGF, sFlt-1) and novel markers of endothelial dysfunction and cell damage (e.g., cfDNA, microvesicles) allowed us to explore their complementary value. Here, PGF is linked to endothelial dysfunction.